CHU Brugmann
Brussels, 1020, Belgium
NCT Number: NCT03346512
This is a retrospective observational study of the transfusion threshold in cardiac surgery.
There is controversy in the literature regarding the transfusion threshold to be adopted, especially in a patient who has undergone cardiac surgery. Some authors suggest that the transfusion should be done in a restrictive way when a certain threshold in hemoglobin is reached, in order to avoid the risks it implies, especially infectious.This threshold is very controversial and remains to be defined (variations in the literature from 7g / dL to 9g / dL). Other authors conclude that there is no superiority of a restrictive transfusion compared to a more liberal transfusion, with regard to the morbidity or medical costs.
It is therefore interesting to study, in a retrospective manner, the global and multidisciplinary management of patients who have undergone a cardiac surgery within the CHU Brugmann hospital, to analyze if they have been adequately transfused.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Brussels, 1020, Belgium
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Cardiac surgery
Time frame: Baseline (just before cardiac surgery)
Hemoglobin rate
Time frame: One day after surgery (J1)
Hemoglobin rate
Time frame: Two days after surgery (J2)
Hemoglobin rate
Time frame: Five days after surgery (J5)
Hemoglobin rate
Time frame: Baseline (just before cardiac surgery)
Hematocrit rate
Time frame: One day after surgery (J1)
Hematocrit rate
Time frame: Two days after surgery (J2)
Hematocrit rate
Time frame: Five days after surgery (J5)
Hematocrit rate
Time frame: Baseline (just before cardiac surgery)
Coagulation indicator
Time frame: One day after surgery (J1)
Coagulation indicator
Time frame: Two days after surgery (J2)
Coagulation indicator
Time frame: Five days after surgery (J5)
Coagulation indicator
Time frame: Baseline (just before cardiac surgery)
Renal function indicator
Time frame: One day after surgery (J1)
Renal function indicator
Time frame: Two days after surgery (J2)
Renal function indicator
Time frame: Five days after surgery (J5)
Renal function indicator
Time frame: Five days after surgery (J5)
Total amount of blood perfusions
Time frame: One day after surgery
Ratio between total fluid intake (perfusion) and loss (blood and urine)
Looking for future studies?
Notify MePierre Wauthy
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07841327
Cardiac Surgery, Left Ventricular Function
Cairo, Cairo Governorate, Egypt
View Trial DetailsNCT07837037
Acute Kidney Injury, Cardiac Surgery
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT05885230
Cardiac Surgery
Banī Suwayf, e\EYGPT, Egypt
View Trial DetailsNCT07783204
Cardiac Surgery, Frailty
Bursa, Nilüfer, Turkey (Türkiye)
View Trial Details